A forum for researchers, students and applicants in the field of cyclodextrin technology
This workshop is part of the NextNano4Cancer project, funded under the ERA4Health Joint Transnational Call “Nano and advanced technologies for
In the quest for greener materials, scientists are turning their attention to an unlikely hero — hydrogels, those soft, water-filled
This second-generation delivery device provides a cost-efficient alternative to in-hospital treatment. Lasix® ONYU represents the most recent FDA-approved formulation incorporating
Chemists Susumu Kitagawa, Richard Robson and Omar Yaghi won the 2025 Nobel Prize in Chemistry for developing the world’s most
All these studies utilize the high solubilizing effect of 2,6-di-O-methyl beta-cyclodextrin studying various model drugs. The compatibility, inclusion stability, and
The unique physicochemical properties of cupric oxide nanoparticles (CuO NPs) make them suitable for a wide range of therapeutic applications.
Pediatric drug development faces notable challenges due to age-related physiological differences, with limited approved formulations often leading to off-label or
This article investigates the complexation of astilbin (Ast), a poorly soluble flavonoid, with methyl-β-cyclodextrin (M-β-CD) to enhance its solubility, stability,
Breast cancer remains the most prevalent malignancy among women and the second leading cause of cancer-related mortality worldwide, primarily attributable
The high occurrence of melanoma and its associated poor prognosis highlight the need for exploring new and innovative treatment strategies.
